LUNGLIFE AI
LungLife AI is a molecular diagnostics company that involves in the early detection and treatment of cancer. It uses machine learning and artificial intelligence to enable life-saving early diagnosis of lung cancer. The company focused on transforming cancer diagnosis and management through artificial intelligence (AI) enabled the molecular analysis of cancer biomarkers in blood. The company is developing tests that span all stages of lung cancer from aid in diagnosis for patients with early-st... age disease to treatment stratification and monitoring in late-stage lung cancer. The company's diagnostic technology combined with machine learning and image analysis results in workflow efficiencies and improvement in performance. It was founded in 2008 and is headquartered in Thousand Oaks, California.
LUNGLIFE AI
Industry:
Artificial Intelligence Biotechnology Health Diagnostics Machine Learning Medical
Founded:
2006-01-01
Address:
Thousand Oaks, California, United States
Country:
United States
Website Url:
http://www.lunglifeai.com
Total Employee:
1+
Status:
Active
Contact:
+1 (805) 409-9868
Total Funding:
45.83 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Biomoda
Biomoda operates as an in vitro diagnostics company that develops assays and tests to detect cancer.
Biotheranostics
Biotheranostics is a commercial-stage molecular diagnostics company that support physicians in the treatment of cancer patients.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
OncoMethylome
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer.
PetDx
PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.
Petuum
Petuum, Inc. is building a platform that serves the full spectrum of Artificial Intelligence
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Greenwoods Asset Management
Greenwoods Asset Management investment in Series B - LungLife AI
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group investment in Series B - LungLife AI
Syno Capital
Syno Capital investment in Series B - LungLife AI
Official Site Inspections
http://www.lunglifeai.com Semrush global rank: 8.73 M Semrush visits lastest month: 261
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "LungLife AI"
About Us - LungLife AI
Roy has extensive experience spanning medical devices, diagnostics, and the digital healthcare space. He is currently Chairman of Medica Group PLC, the UK’s leading teleradiology company, Foster & Freeman Limited, a leading …See details»
Annual Report 2023 - LungLife AI
Dec 31, 2023 Website www.lunglifeai.com. 2 LungLife AI, Inc. Chairman’s statement ... According to the World Health Organization, over 2.2 million new cases of lung cancer were …See details»
(the “Company” or “LungLife”) - investors.lunglifeai.com
Walbrook PR Limited Tel: +44 (0)20 7933 8780 or [email protected] Stephanie Cuthbert / Alice Woodings / Phillip Marriage Mob: 07980 541 893 / 07407 804 654 / 07867 984 …See details»
LungLife AI (AIM:LLAI) Company Profile & Description - Stock …
6 days ago 2545 West Hillcrest Drive Thousand Oaks, Delaware 91320 United StatesSee details»
LungLife AI - LinkedIn
LungLife AI | 775 followers on LinkedIn. LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analysis of biomarkers in blood. | LungLife is a developer of clinical ...See details»
LungLife AI - Crunchbase Company Profile & Funding
LungLife AI planned to leave AIM due to financial difficulties, with cash only lasting until later in the second quarter. The company also indicated intentions to exit the AIM market and potentially wind up due to a lack of strategic …See details»
LungLife AI - Craft
Oct 29, 2024 LungLife AI has 4 employees at their 1 location and $46 k in annual revenue in FY 2023. See insights on LungLife AI including office locations, competitors, revenue, financials, …See details»
LungLife AI
Website www.lunglifeai.com. 2 LungLife AI, Inc. Chairman’s statement ... According to the World Health Organization, over 2.2 million new cases of lung cancer were diagnosed in 2020 and …See details»
LungLife AI 2025 Company Profile: Stock Performance …
LungLife AI General Information Description. LungLife AI Inc is focused on a developing clinical diagnostic solutions for lung cancer. The Company generates revenue from People's Republic of China and also has its presence in the …See details»
LungLifeAI | Circulogene | Tumor Detection
LungLifeAI is powered by a proprietary 4-color fluorescence in situ hybridization (FISH) assay that identifies Circulating Genetically Abnormal Cells (CGACs) in a standard blood sample. These …See details»
News - LungLife AI
LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, makes the following six monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the …See details»
LungLife AI, Inc. Company LungLife
Walbrook PR Limited Tel: +44 (0)20 7933 8780 or [email protected] . Paul McManus / Alice Woodings / Phillip Marriage Mob: 07980 541 893 / 07407 804 654 / 07867 984 082 …See details»
Organization: LungLife AI LEI 549300VBVDIF0Y3OVI38 - Cbonds.com
Organization name. LungLife AI, Inc. Country name. USA Country of registration. USA. Industry. Medical Devices. Bond debt - Find Any Data on Any Bond in Just One Click. Full data on over …See details»
Using Artificial Intelligence To Diagnose Lung Cancer - Forbes
May 26, 2020 LungLife AI says it's using artificial intelligence (AI) to diagnose lung cancer from a minimal blood draw. The health tech startup has raised $45.8 M in funding and is focusing on …See details»
LungLifeAI achieves cancer diagnosis with AI & ML - Persistent …
LungLifeAI, a pioneer in LiquidBiopsy® technology, uses machine learning and artificial intelligence to enable life-saving early diagnosis of lung cancer. Take a look at how …See details»
Our Story so Far - LungLife AI
Peer-reviewed publication of a cost effectiveness analysis model on LungLB providing evidence the test can be utilised as a cost-effective alternative to the current diagnostic pathway.See details»
Circulogene Announces Exclusive Commercial Launch of …
2 days ago PENSACOLA, Fla., May 13, 2025 /PRNewswire/ -- Circulogene is excited to announce the exclusive commercial launch of LungLifeAI®, a breakthrough AI-driven blood …See details»
LungLife AI, Inc. Company LungLife Half-year Report
Sep 26, 2022 LungLife AI, Inc. www.lunglifeai.com Paul Pagano, CEO Via Walbrook PR David Anderson, CFO Investec Bank plc (Nominated Adviser & Broker) Tel: +44 (0)20 7597 5970 …See details»
Financial Information / Documents & Presentations - LungLife AI
Circular to Shareholders - April 2025. Financial Information Documents & Presentations. Circular to Shareholders - April 2025See details»
LungLife AI, Inc. Company LungLife Preliminary audited results for …
Walbrook PR Limited Tel: +44 (0)20 7933 8780 or [email protected] Stephanie Cuthbert / Alice Woodings / Phillip Marriage Mob: 07980 541 893 / 07407 804 654 / 07867 984 …See details»